Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | MTB-9655 |
Synonyms | |
Therapy Description |
MTB-9655 selectively inhibits ACSS2, potentially resulting in antitumor activity (Cancer Res 2022;82(12_Suppl):Abstract nr 2326). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MTB-9655 | MTB 9655|MTB9655 | MTB-9655 selectively inhibits ACSS2, potentially resulting in antitumor activity (Cancer Res 2022;82(12_Suppl):Abstract nr 2326). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04990739 | Phase I | MTB-9655 | Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors | Unknown status | USA | 1 |